On the Occasion of Its General Meeting, France Biotech Appoints Four New Members on Its Board of Directors and Amends Its Statutes

PARIS--(BUSINESS WIRE)--Following its Annual General Meeting, held on Thursday 24th June, in Paris, France Biotech, the French life sciences industry association (www.france-biotech.org), reappointed its Board of Directors and amended its Statutes. Gilles Avenard, MD, (BioAlliance Pharma), Franck Grimaud (Vivalis), and Loïc Maurel , MD, (ExonHit Therapeutics) are reelected as Members of the Board.